VR Logo

Astrazeneca Pharma India Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

40 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

Incorporated: 1979

Chairman: Narayan K Seshadri

Managing Director: Gagandeep Singh Bedi

Group: Astrazeneca Pharma India - MNC

Listing: NSE: ASTRAZEN, BSE: 506820

Headquarters: Bengaluru, Karnataka

Website: www.astrazenecaindia.com

Key Facts

Market cap: R 8,538.88 Cr

Revenue (TTM): R 831.81 Cr

Earnings (TTM): R 72.21 Cr

Cash: R 252.52 Cr

Total Debt: R 0.00 Cr

Promoters' ownership: 75.00%

Liquidity: High

52 Week range: R 1,632.55 - 3,700.00

Face value: R2.00

Shares outstanding: 2,50,00,000

10 Years Aggregate:

  • CFO: 296.96 Cr
  • EBITDA: 332.84 Cr
  • Net Profit: 150.89 Cr

Stock Performance

Time Period Astrazeneca Pharma India S&P BSE Healthcare S&P BSE Mid Cap
YTD30.6238.73-7.43
1 month-2.7313.994.27
3 months5.4121.2520.46
1 Year80.0047.902.27
3 Years55.4110.30-3.53
5 Years23.421.713.87
10 Years10.7012.746.30
As on 04-Aug-2020
Year Astrazeneca Pharma India S&P BSE Mid Cap S&P BSE Healthcare
201981.26-3.05-3.55
201824.22-13.31-5.89
201726.0048.130.49
2016-26.417.97-12.88
201543.317.4315.06
20142.9454.6947.43
2013-37.81-5.7322.55